Frank L. Custers

642 total citations
12 papers, 442 citations indexed

About

Frank L. Custers is a scholar working on Pulmonary and Respiratory Medicine, Neurology and Surgery. According to data from OpenAlex, Frank L. Custers has authored 12 papers receiving a total of 442 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pulmonary and Respiratory Medicine, 4 papers in Neurology and 2 papers in Surgery. Recurrent topics in Frank L. Custers's work include Pleural and Pulmonary Diseases (3 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (3 papers) and Neuroblastoma Research and Treatments (3 papers). Frank L. Custers is often cited by papers focused on Pleural and Pulmonary Diseases (3 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (3 papers) and Neuroblastoma Research and Treatments (3 papers). Frank L. Custers collaborates with scholars based in Netherlands, Australia and United States. Frank L. Custers's co-authors include Eddy van Doorslaer, JA Raaijmakers, F. P. V. Maesen, Maureen Rutten‐van Mölken, Paul Baas, P. J. G. Cornelissen, J.J. Smeets, Lawrence Korducki, J.A. van Noord and A. Haringhuizen and has published in prestigious journals such as Journal of Clinical Oncology, The Lancet Oncology and European Respiratory Journal.

In The Last Decade

Frank L. Custers

10 papers receiving 414 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Frank L. Custers Netherlands 8 327 194 63 41 26 12 442
T. Svahn United States 6 255 0.8× 304 1.6× 77 1.2× 21 0.5× 20 0.8× 8 510
Peter Dale United Kingdom 11 202 0.6× 245 1.3× 39 0.6× 52 1.3× 8 0.3× 24 412
BL Barber United States 6 268 0.8× 279 1.4× 24 0.4× 41 1.0× 14 0.5× 15 482
Iain Small United Kingdom 10 410 1.3× 347 1.8× 34 0.5× 9 0.2× 23 0.9× 23 545
Kathy Rickard United States 12 432 1.3× 461 2.4× 48 0.8× 13 0.3× 21 0.8× 24 589
Angela Cairns United Kingdom 5 90 0.3× 82 0.4× 41 0.7× 30 0.7× 10 0.4× 8 316
T Evald Denmark 13 280 0.9× 313 1.6× 29 0.5× 7 0.2× 6 0.2× 18 470
Sarah Smith United Kingdom 11 108 0.3× 36 0.2× 51 0.8× 23 0.6× 15 0.6× 30 286
Karen House United States 12 705 2.2× 736 3.8× 15 0.2× 12 0.3× 16 0.6× 19 830
Sandra L. Horne Canada 8 278 0.9× 218 1.1× 32 0.5× 5 0.1× 13 0.5× 14 447

Countries citing papers authored by Frank L. Custers

Since Specialization
Citations

This map shows the geographic impact of Frank L. Custers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frank L. Custers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frank L. Custers more than expected).

Fields of papers citing papers by Frank L. Custers

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frank L. Custers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frank L. Custers. The network helps show where Frank L. Custers may publish in the future.

Co-authorship network of co-authors of Frank L. Custers

This figure shows the co-authorship network connecting the top 25 collaborators of Frank L. Custers. A scholar is included among the top collaborators of Frank L. Custers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frank L. Custers. Frank L. Custers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Roozendaal, Lori M. van, et al.. (2020). Bronchopleural Fistula After Concurrent Chemoradiotherapy. Advances in Radiation Oncology. 5(3). 511–515. 2 indexed citations
2.
Gronenschild, Michiel H. M., et al.. (2020). Minimally Invasive Approach to Esophageal Perforation after Endoscopic Ultrasound-Guided Fine-Needle Aspiration: A Report of 2 Cases. The Korean Journal of Thoracic and Cardiovascular Surgery. 53(5). 313–316.
3.
Nakken, Nienke, Daisy J.A. Janssen, Jean Muris, et al.. (2017). Knowledge gaps in patients with COPD and their proxies. BMC Pulmonary Medicine. 17(1). 136–136. 37 indexed citations
4.
Nakken, Nienke, Martijn A. Spruit, Monique van Vliet, et al.. (2016). Health Status and Morbidities in Resident Relatives of Patients With COPD. Journal of the American Medical Directors Association. 17(3). 276.e1–276.e8. 12 indexed citations
5.
Buikhuisen, Wieneke A., Jacobus A. Burgers, Andrew Vincent, et al.. (2013). Thalidomide versus active supportive care for maintenance in patients with malignant mesothelioma after first-line chemotherapy (NVALT 5): an open-label, multicentre, randomised phase 3 study. The Lancet Oncology. 14(6). 543–551. 57 indexed citations
6.
Baas, Paul, Wieneke A. Buikhuisen, A. Vincent, et al.. (2011). A multicenter, randomized phase III maintenance study of thalidomide (arm A) versus observation (arm B) in patients with malignant pleural mesothelioma (MPM) after induction chemotherapy.. Journal of Clinical Oncology. 29(15_suppl). 7006–7006. 10 indexed citations
7.
Cappuzzo, Federico, Bruno Coudert, Ryszard Wierzbicki, et al.. (2009). 9158 A phase III study of erlotinib as maintenance therapy in NSCLC to delay progression following first-line chemotherapy (SATURN). European Journal of Cancer Supplements. 7(2). 553–553. 5 indexed citations
8.
Cappuzzo, Federico, Bruno Coudert, Ryszard Wierzbicki, et al.. (2009). 22LBA Overall survival analyses from the SATURN phase III placebo-controlled study of erlotinib as first-line maintenance therapy in advanced non-small-cell lung cancer (NSCLC). European Journal of Cancer Supplements. 7(3). 13–13. 11 indexed citations
9.
Scholte, Jan, Judith Potjewijd, P.J. Voogt, Frank L. Custers, & Kon‐Siong G. Jie. (2009). [Interstitial pneumonitis as an adverse effect of thalidomide].. PubMed. 153. A452–A452. 1 indexed citations
10.
Baas, Paul, Willem Boogerd, Otilia Dalesio, et al.. (2004). Thalidomide in patients with malignant pleural mesothelioma. Lung Cancer. 48(2). 291–296. 68 indexed citations
11.
Noord, J.A. van, J.J. Smeets, Frank L. Custers, Lawrence Korducki, & P. J. G. Cornelissen. (2002). Pharmacodynamic steady state of tiotropium in patients with chronic obstructive pulmonary disease. European Respiratory Journal. 19(4). 639–644. 72 indexed citations
12.
Mölken, Maureen Rutten‐van, et al.. (1995). Comparison of performance of four instruments in evaluating the effects of salmeterol on asthma quality of life. European Respiratory Journal. 8(6). 888–898. 167 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026